₹ 14878 / 43 shares

IPO Details


Issue Date


Min Investments

₹ 14878

Issue Price


Lot Size


IPO Size

₹ 840.27 Cr

IPO Listing Details

Listing On

1 Nov'23

Issue Price


Listed Price

₹ 380

Retail Gain/Listing Gain


Watch and Learn
All you need to know about Blue Jet Healthcare IPO
Tune in to know more about the company, IPO issue details, future strategies, important financial details, its presence and reach, service portfolio, and much more with Kinjal Parekh!

Blue Jet Healthcare Limited is a specialty pharmaceutical and healthcare ingredients and intermediates company, offering niche products targeted toward innovator pharmaceutical companies and multi-national generic pharmaceutical companies. The company has manufacturing capabilities in contrast media intermediates and high-intensity sweeteners, including saccharin and its salts.

The company’s operations are primarily organised into three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (APIs).

In the past three Financial Years and the three months ended June 30, 2023, the company invoiced more than 400 customers in 39 countries. They have built a long-term customer base with innovator pharmaceutical companies and multi-national generic pharmaceutical companies, supported by committed multi-year contracts of up to five years.

With that, let's take a look at the competitive strengths and risk factors for Blue Jet Healthcare Limited:

Large manufacturer of contrast media intermediates in India
Read More
Presence in niche categories with high barriers to entry
Read More
Long-standing relationships and multi-year contracts with multi-national customers
Read More
  • The business is dependent on the sale of products to a limited number of key customers.
  • The business is dependent on Europe and the United States, which are regulated markets, for a significant portion of their revenue from operations.
  • If the company is not able to commercialise new products in a timely manner, the business, financial condition and prospects will be adversely affected.
  • Continue to integrate into more advanced intermediates for contrast media.
  • Build additional production capacity to keep in step with the envisaged increase in customer demands.
  • Focus on operational efficiency and mitigation of supply chain risks.

Here are the key financials for Blue Jet Healthcare Limited:

Particulars (in Rs. million)

What are you looking for?
Applying for an IPO for the first time?
Here's a video playlist to help you invest in Blue Jet Healthcare Limited IPO
How to apply for IPO through ASBA

How to apply for IPO through ASBA

Kotak Securities

00m 59s

Blue Jet Healthcare Limited FAQs

The Blue Jet Healthcare Limited IPO has an issue size of Rs. 840.27 crores. The IPO opens for subscription on 25th October and closes on 27th October 2023.

Link Intime India Private Limited is the registrar for this IPO.

You may read more about Blue Jet Healthcare Limited and its IPO from the company’s red herring prospectus (RHP) here:

Open Demat Account to Invest in any IPO
+91 -